熱門資訊> 正文
Reviva Pharmaceuticals宣布公开募股;股价下跌近15%
2025-06-26 04:28
- Reviva Pharmaceuticals (NASDAQ:RVPH) plans to offer common stock or equivalents and warrants in a public offering.
- All securities in the offering will be sold by the company.
- Proceeds will support R&D efforts, working capital, and general corporate purposes.
- RVPH shares fall nearly 15% post-market on Wednesday.
- Source: Press release
More on Reviva Pharmaceuticals
- Seeking Alpha’s Quant Rating on Reviva Pharmaceuticals
- Historical earnings data for Reviva Pharmaceuticals
- Financial information for Reviva Pharmaceuticals
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
